2024 Membership

2024 Revised Charges:

The Pharmaceutical Benefit Management Regulatory Issues (B) Working Group will:

1. Serve as a forum to educate state insurance regulators on issues related to pharmacy benefit manager (PBM) regulation and other stakeholders in the prescription drug ecosystem.
2. Gather and share information, best practices, experience, and data to inform and support dialogue and information-sharing among state insurance regulators on issues related to PBM regulation, such as examinations and contracting, and pharmaceutical drug pricing and transparency.
3. As the subject matter experts (SMEs) and to promote uniformity across the states, while remaining sensitive to the variation in state approaches, develop a chapter for inclusion in the Market Regulation Handbook establishing examination standards for PBMs and related regulated entities for referral and consideration by the Market Conduct Examination Guidelines (D) Working Group.
4. Maintain a current listing of PBM laws and regulations and case law for reference by state insurance regulators.
5. Disseminate materials and reports, via the NAIC, to the states and the U.S. territories wishing to use the information gathered by the Working Group.
6. Monitor, facilitate, and coordinate with the states and federal agencies to ensure compliance and enforcement efforts regarding PBMs.